Manas AI

AI · Healthcare · Biotech

Funding

Reid Hoffman reportedly raises $24.6M for AI cancer startup Manas AI

Pairing a serial tech founder with a Pulitzer-winning oncologist aims to compress years of cancer drug discovery into months.

• Reid Hoffman, LinkedIn's co-founder, has raised $24.6 million for Manas AI, a new AI-driven cancer-research venture, according to reports citing the Wall Street Journal.
• Manas AI pairs Hoffman's experience scaling tech platforms with co-founder Siddhartha Mukherjee, the Columbia oncologist whose book 'The Emperor of All Maladies' won the Pulitzer Prize.
• The startup intends to apply machine learning to large genomic and clinical datasets to identify new cancer therapeutic targets and speed early-stage drug development.
• Hoffman previously turned a stalled first attempt, SocialNet, into lessons that shaped LinkedIn, which he eventually helped grow into a $26.2 billion exit.
• The raise reflects growing investor appetite for combining AI engineering talent with deep clinical expertise to attack slow, expensive oncology drug discovery.